Gruia G - Search Results

1

Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.

Rocha Lima CM, Green MR, Rotche R, Miller WH Jr, Jeffrey GM, Cisar LA, Morganti A, Orlando N, Gruia G, Miller LL. Rocha Lima CM, et al. Among authors: gruia g. J Clin Oncol. 2004 Sep 15;22(18):3776-83. doi: 10.1200/JCO.2004.12.082. J Clin Oncol. 2004. PMID: 15365074 Clinical Trial.

2

Phase 1 and pharmacokinetic study of intravenous irinotecan in refractory solid tumor patients with hepatic dysfunction.

Schaaf LJ, Hammond LA, Tipping SJ, Goldberg RM, Goel R, Kuhn JG, Miller LL, Compton LD, Cisar LA, Elfring GL, Gruia G, McGovren JP, Pirotta N, Yin D, Sharma A, Duncan BA, Rothenberg ML. Schaaf LJ, et al. Among authors: gruia g. Clin Cancer Res. 2006 Jun 15;12(12):3782-91. doi: 10.1158/1078-0432.CCR-05-2152. Clin Cancer Res. 2006. PMID: 16778106 Clinical Trial.

3

Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard.

Saltz LB, Douillard JY, Pirotta N, Alakl M, Gruia G, Awad L, Elfring GL, Locker PK, Miller LL. Saltz LB, et al. Among authors: gruia g. Oncologist. 2001;6(1):81-91. doi: 10.1634/theoncologist.6-1-81. Oncologist. 2001. PMID: 11161231 Free article. Clinical Trial.

4

Phase I and pharmacokinetic study of irinotecan administered as a low-dose, continuous intravenous infusion over 14 days in patients with malignant solid tumors.

Herben VM, Schellens JH, Swart M, Gruia G, Vernillet L, Beijnen JH, ten Bokkel Huinink WW. Herben VM, et al. Among authors: gruia g. J Clin Oncol. 1999 Jun;17(6):1897-905. doi: 10.1200/JCO.1999.17.6.1897. J Clin Oncol. 1999. PMID: 10561231 Clinical Trial.

5

Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver.

van Riel JM, van Groeningen CJ, de Greve J, Gruia G, Pinedo HM, Giaccone G. van Riel JM, et al. Among authors: gruia g. Ann Oncol. 2004 Jan;15(1):59-63. doi: 10.1093/annonc/mdh022. Ann Oncol. 2004. PMID: 14679121 Free article. Clinical Trial.

6

Treatment with a nonanthracycline regimen in advanced breast cancer: vinorelbine, cyclophosphamide, and 5-fluorouracil with folinic acid.

Turpin F, Lluch A, Closon MH, Gruia G, Llombart A, Fernandez R, Delgado FM, Biville F. Turpin F, et al. Among authors: gruia g. Am J Clin Oncol. 1999 Apr;22(2):196-8. doi: 10.1097/00000421-199904000-00021. Am J Clin Oncol. 1999. PMID: 10199461 Clinical Trial.

7

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer.

Van Cutsem E, Pozzo C, Starkhammar H, Dirix L, Terzoli E, Cognetti F, Humblet Y, Garufi C, Filez L, Gruia G, Cote C, Barone C. Van Cutsem E, et al. Among authors: gruia g. Ann Oncol. 1998 Nov;9(11):1199-204. doi: 10.1023/a:1008478405634. Ann Oncol. 1998. PMID: 9862050 Free article. Clinical Trial.

8

A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer.

Schoemaker NE, Kuppens IE, Moiseyenko V, Glimelius B, Kjaer M, Starkhammer H, Richel DJ, Smaaland R, Bertelsen K, Poulsen JP, Voznyi E, Norum J, Fennelly D, Tveit KM, Garin A, Gruia G, Mourier A, Sibaud D, Lefebvre P, Beijnen JH, Schellens JH, ten Bokkel Huinink WW. Schoemaker NE, et al. Among authors: gruia g. Br J Cancer. 2004 Oct 18;91(8):1434-41. doi: 10.1038/sj.bjc.6602172. Br J Cancer. 2004. PMID: 15381932 Free PMC article. Clinical Trial.

9

Phase I study of irinotecan and raltitrexed in patients with advanced gastrointestinal tract adenocarcinoma.

Ford HE, Cunningham D, Ross PJ, Rao S, Aherne GW, Benepal TS, Price T, Massey A, Vernillet L, Gruia G. Ford HE, et al. Among authors: gruia g. Br J Cancer. 2000 Jul;83(2):146-52. doi: 10.1054/bjoc.2000.1192. Br J Cancer. 2000. PMID: 10901362 Free PMC article. Clinical Trial.

10

Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer.

Misset JL, Dieras V, Gruia G, Bourgeois H, Cvitkovic E, Kalla S, Bozec L, Beuzeboc P, Jasmin C, Aussel JP, Riva A, Azli N, Pouillart P. Misset JL, et al. Among authors: gruia g. Ann Oncol. 1999 May;10(5):553-60. doi: 10.1023/a:1026418831238. Ann Oncol. 1999. PMID: 10416005 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters